A CASE STUDY ON CLINICAL PHARMACIST INTERVENTIONS IN THE MANAGEMENT OF DIABETES COMPLICATED CORONARY ARTERY DISEASE IN HEALTH-CARE PRACTICE

  • BHARATH KUMAR A Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
  • UMASHANKAR MS Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.

Abstract

Objective: The objective of the study was to assess the clinical pharmacist interventions in the management of diabetes complicated coronary artery disease.


Methods: In the present study, a case history of a 55-year-old female was suffering from diabetes with coronary artery disease was taken. The case was collected from the cardiology outpatient department in a tertiary care hospital. The case was analyzed from 1 to 3 months. The initial visit to the end of final visit her laboratory parameters was examined at the laboratory.


Results: The test report of electrocardiogram revealed sinus rhythm. The patient was advised for an echocardiogram which confirmed coronary artery disease. The patient was subjected to a coronary angiogram, which revealed the presence of double-vessel disease. Her ankle-brachial index study test revealed peripheral artery disease. The patient was diagnosed with coronary artery disease, and she was prescribed with regular medications. The patient was monitored for 1-week duration and prescribed with coronary artery disease medications to normalize the condition. The patient was improved with the treatment and advised for regular follow-ups.


Conclusion: The study concludes that there was an imperative need for regular health screening by the physician associated clinical pharmacist care services with an effective treatment modality that can reduce the coronary artery disease incidences in this patient.

Keywords: Diabetes mellitus, Coronary artery disease, Peripheral artery disease, Clinical pharmacist service

References

1. Chen J, Zhang Y, Liu J, Chen MH, Guo YL, Zhu CG, et al. Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in Type 2 diabetics: A Gensini score evaluation. Diab Vasc Dis Res 2015;12:258-64.
2. Valensi P, Avignon A, Sultan A, Chanu B, Nguyen MT, Cosson E. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with Type 2 diabetes: A cross-sectional study. Cardiovasc Diabetol 2016;15:104.
3. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with Type 2 diabetes. N Engl J Med 2009;360:129-39.
4. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: Therapeutic options in patients with diabetes. J Am Coll Cardiol 2000;36:355-65.
5. Zhao SJ, Zhao HW, Du S, Qin YH. The impact of clinical pharmacist support on patients receiving multi-drug therapy for coronary heart disease in China. Indian J Pharm Sci 2015;77:306-11.
6. Chhajer B, Singh V, Kumari G, Lohmor M. Effect of yoga based lifestyle intervention on coronary artery disease patients. Biomed Pharmacol J 2018;11:1275-89.
7. Shao H, Chen G, Zhu C, Chen Y, Liu Y, He Y, et al. Effect of pharmaceutical care on clinical outcomes of outpatients with Type 2 diabetes mellitus. Patient Prefer Adherence 2017;11:897-903.
8. Kandasamy K, Konakalla M, Sam R, Sebastian J, Natarajan A, Rajagopal SS, et al. A pilot study on the impact of pharmacist intervention in Type-2 diabetes mellitus counselling program in a rural community. Indian J Pharm Sci 2017;79:701-706.
9. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81.
10. Tazhiyeva A, Reznik V, Abylayuly Z, Kozhayeva GK. The opinion of therapists and specialized doctors on the provision of medical assistance of patients with Type 2 diabetes in polyclinics in almaty. Int J App Pharm 2019;11:30-6.
11. Sauriasari R, Sakti RM. Impact of a pharmacist-led patient education initiative on glycemic control of patients with Type 2 diabetes mellitus: A single-center experience in West Jakarta, Indonesia. Int J Appl Pharm 2018;10:252-6.
12. Presetiawati N 2nd, Andrajati R, Sauriasari R. Effectiveness of a medication booklet and counseling on treatment adherence in Type 2 diabetes mellitus patients. Int J Appl Pharm 2017;19:28-31.
13. Adikusuma W, Qiyaam N. Adherence level and blood sugar control of Type 2 diabetes mellitus patients who gets counseling and short messages service as reminder and motivation. Asian J Pharm Clin Res 2018;11:219-22.
14. Manikandan R, Sudha NS, Logaraj M. Assessment of medication adherence among patients with hypertension and diabetes mellitus in urban field practice. Asian J Pharm Clin Res 2018;11:130-2.
15. Jain R, Jain P, Jain P. A review on treatment and prevention of diabetes mellitus. Int J Curr Pharm Res 2016;8:16-8.
16. Rabba AK, Aljiris WS, Ahmed NJ, Alkharfy KM. Short communication medication adherence in Type 2 diabetic patients: A study in Saudi Arabia. Int J Pharm Pharm Sci 2017;9:9-12.
17. Omar MS, San KL. Diabetes knowledge and medication adherence among geriatric patient with Type 2 diabetes mellitus. Int J Pharm Pharm Sci 2014;6:103-6.
18. Adepu R, Madhu S. Influence of post discharge counseling on health outcomes in diabetic and hypertensive patients. Asian J Pharm Clin Res 2011;4:28-33.
19. Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with Type 2 diabetes. Diabetes Educ 2011;37:801-12.
Statistics
277 Views | 197 Downloads
Citatons
How to Cite
KUMAR A, B., and U. MS. “A CASE STUDY ON CLINICAL PHARMACIST INTERVENTIONS IN THE MANAGEMENT OF DIABETES COMPLICATED CORONARY ARTERY DISEASE IN HEALTH-CARE PRACTICE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 4, Feb. 2020, pp. 1-4, doi:10.22159/ajpcr.2020.v13i4.36742.
Section
Case Study(s)